Previous diagnoses of COPD and HF under optimized clinical treatment as judged by the accompanying physician
Reduced left ventricular ejection fraction (<50%)
Non-reversible airway obstruction (post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 80 %)
Respiratory muscle weakness (Pi,max < 70cmH2O)
Persistent dyspnea on daily life (Baseline Dyspnea Index focal score <or= 8).

NCT02579200_inc_T1
Condition
COPD
NCT02579200_inc_T2
Condition
HF
NCT02579200_inc_T3
Procedure
clinical treatment
NCT02579200_inc_T4
Qualifier
optimized
NCT02579200_inc_T5
Scope
COPD and HF
NCT02579200_inc_T6
Value
Reduced
NCT02579200_inc_T7
Measurement
left ventricular ejection fraction
NCT02579200_inc_T8
Value
<50%
NCT02579200_inc_T9
Condition
airway obstruction
NCT02579200_inc_T10
Qualifier
Non-reversible
NCT02579200_inc_T11
Measurement
FEV1/FVC
NCT02579200_inc_T12
Qualifier
post-bronchodilator
NCT02579200_inc_T13
Value
< 0.7
NCT02579200_inc_T14
Measurement
FEV1
NCT02579200_inc_T15
Value
< 80 %
NCT02579200_inc_T16
Scope
post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 80 %
NCT02579200_inc_T17
Scope
Non-reversible airway obstruction
NCT02579200_inc_T18
Condition
Respiratory muscle weakness
NCT02579200_inc_T19
Measurement
Pi,max
NCT02579200_inc_T20
Value
< 70cmH2O
NCT02579200_inc_T21
Condition
dyspnea on daily life
NCT02579200_inc_T22
Temporal
Persistent
NCT02579200_inc_T23
Temporal
Baseline
NCT02579200_inc_T24
Measurement
Dyspnea Index focal score
NCT02579200_inc_T25
Value
<or= 8
NCT02579200_inc_T26
Scope
Baseline Dyspnea Index focal score <or= 8
NCT02579200_inc_T27
Scope
Persistent dyspnea on daily life